Published in J Exp Med on June 01, 1993
Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev (2008) 4.14
TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation (2008) 3.19
Mechanism of action of lenalidomide in hematological malignancies. J Hematol Oncol (2009) 2.48
Role of TNFalpha in pulmonary pathophysiology. Respir Res (2006) 2.27
Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J Clin Invest (1997) 2.23
Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection. Infect Immun (1997) 1.95
Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev (2009) 1.90
TNF-alpha and neuropathic pain--a review. J Neuroinflammation (2010) 1.68
Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J Exp Med (1996) 1.61
Pomalidomide is nonteratogenic in chicken and zebrafish embryos and nonneurotoxic in vitro. Proc Natl Acad Sci U S A (2013) 1.55
Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence. CNS Drugs (2014) 1.49
Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis. Mol Med (1995) 1.46
Cancer cachexia: mechanisms and clinical implications. Gastroenterol Res Pract (2011) 1.45
The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats. Brain Res (2008) 1.45
Immunomodulation by thalidomide and thalidomide analogues. Ann Rheum Dis (1999) 1.40
Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat. J Neuroinflammation (2016) 1.38
The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures. Clin Exp Immunol (1995) 1.37
Properties of thalidomide and its analogues: implications for anticancer therapy. AAPS J (2005) 1.33
Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs. PLoS Pathog (2011) 1.29
TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation. J Neuroinflammation (2012) 1.29
Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity. Mol Med (1996) 1.24
A review of current and novel therapies for idiopathic pulmonary fibrosis. J Thorac Dis (2013) 1.18
Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. CNS Neurol Disord Drug Targets (2011) 1.16
Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells. Immunology (1994) 1.16
Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease. J Neuroinflammation (2012) 1.13
Thalidomide and derivatives: immunological investigations of tumour necrosis factor-alpha (TNF-alpha) inhibition suggest drugs capable of selective gene regulation. Clin Exp Immunol (1997) 1.10
Thalidomide-induced symptomatic third-degree atrioventricular block. Clin Res Cardiol (2006) 1.10
Inhibition of endothelial activation: a new way to treat cerebral malaria? PLoS Med (2005) 1.09
Antihyperalgesic effect of pentoxifylline on experimental inflammatory pain. Br J Pharmacol (2004) 1.09
Inflammatory bowel disease: clinical aspects and treatments. J Inflamm Res (2014) 1.07
Thalidomide treatment of mucosal ulcerations in HIV infection. Arch Dis Child (1996) 1.06
Selective leukemic-cell killing by a novel functional class of thalidomide analogs. Blood (2006) 1.06
Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ Res (2015) 1.05
Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells. BMC Cell Biol (2006) 1.05
Tumor necrosis factor-α synthesis inhibitor, 3,6'-dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice. J Neurochem (2011) 1.04
Characterization of the mRNA ligands bound by the RNA binding protein hnRNP A2 utilizing a novel in vivo technique. Nucleic Acids Res (2000) 1.02
Integrated pathways for neutrophil recruitment and inflammation in leprosy. J Infect Dis (2010) 1.00
Small therapeutic molecules for the treatment of inflammatory bowel disease. Gut (2002) 1.00
Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview. Future Microbiol (2011) 1.00
Skin manifestations of drug allergy. Br J Clin Pharmacol (2011) 1.00
Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis. Exp Neurol (2009) 0.99
An open study of pentoxyfylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis. Ann Rheum Dis (1996) 0.98
Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL). Clin Exp Immunol (1998) 0.96
Binding of thalidomide to alpha1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor alpha production. Proc Natl Acad Sci U S A (1996) 0.96
Epidemiological surveillance of birth defects compatible with thalidomide embryopathy in Brazil. PLoS One (2011) 0.95
Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: a phase II open label clinical trial. Amyotroph Lateral Scler (2009) 0.93
Etiology and Management of Recurrent Aphthous Stomatitis. Curr Infect Dis Rep (2003) 0.92
Long-term treatment of thalidomide ameliorates amyloid-like pathology through inhibition of β-secretase in a mouse model of Alzheimer's disease. PLoS One (2013) 0.92
Target population for clinical trials on sarcopenia. J Nutr Health Aging (2008) 0.92
Disseminated herpes simplex virus and varicella zoster virus coinfection in a patient taking thalidomide for relapsed multiple myeloma. J Clin Microbiol (2002) 0.92
Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid. Br J Cancer (1999) 0.91
Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxanthenone-4-acetic acid. Br J Cancer (1995) 0.91
Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res C Embryo Today (2015) 0.90
The critical role of leukotriene B4 in antigen-induced mechanical hyperalgesia in immunised rats. Br J Pharmacol (2003) 0.90
Antiallodynic Effect of Thalidomide and Morphine on Rat Spinal Nerve Ligation-induced Neuropathic Pain. Korean J Pain (2010) 0.89
Salvage therapy for hepatocellular carcinoma with thalidomide. World J Gastroenterol (2004) 0.89
Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma. Acta Biochim Biophys Sin (Shanghai) (2013) 0.88
Biology of TNFalpha and IL-10, and their imbalance in heart failure. Heart Fail Rev (2008) 0.87
Depletion of sirtuin 1 (SIRT1) leads to epigenetic modifications of telomerase (TERT) gene in hepatocellular carcinoma cells. PLoS One (2014) 0.86
Effective immunomodulatory treatment of Escherichia coli experimental sepsis with thalidomide. Antimicrob Agents Chemother (2003) 0.86
Early intervention with a small molecule inhibitor for tumor necrosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer's disease. J Neuroinflammation (2012) 0.86
Effects of thalidomide on the expression of adhesion molecules in rat liver cirrhosis. Mediators Inflamm (2006) 0.86
Modulation of hyperoxia-induced TNF-alpha expression in the newborn rat lung by thalidomide and dexamethasone. Inflammation (2000) 0.86
Thalidomide and its derivatives: emerging from the wilderness. Postgrad Med J (2003) 0.86
Therapeutic and prophylactic thalidomide in TNBS-induced colitis: synergistic effects on TNF-alpha, IL-12 and VEGF production. World J Gastroenterol (2007) 0.86
New therapies in multiple myeloma. Clin Exp Med (2007) 0.86
Update on potential medical treatments for encapsulating peritoneal sclerosis; human and experimental data. Int Urol Nephrol (2010) 0.85
The effect of thalidomide on vascular endothelial growth factor and tumor necrosis factor-alpha levels in retinal ischemia/reperfusion injury. Graefes Arch Clin Exp Ophthalmol (2007) 0.84
Anti-inflammatory effect of α,β-amyrin, a triterpene from Protium heptaphyllum, on cerulein-induced acute pancreatitis in mice. Inflamm Res (2011) 0.84
Treatment of pyoderma gangrenosum with infliximab in Crohn's disease. Dig Dis Sci (2004) 0.84
A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors. J Neurosci Methods (2009) 0.84
Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson's disease. J Neuroinflammation (2015) 0.84
Magnetic resonance imaging for monitoring the effects of thalidomide on experimental human breast cancers. Eur Radiol (2008) 0.83
Thalidomide-a notorious sedative to a wonder anticancer drug. Curr Med Chem (2013) 0.83
Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC). Am J Physiol Gastrointest Liver Physiol (2009) 0.82
Single-dose pharmacokinetics of thalidomide in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (1997) 0.82
The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development. Ther Adv Hematol (2011) 0.82
Intraperitoneal injection of thalidomide attenuates bone cancer pain and decreases spinal tumor necrosis factor-α expression in a mouse model. Mol Pain (2010) 0.82
3,6'-Dithiothalidomide, a new TNF-α synthesis inhibitor, attenuates the effect of Aβ1-42 intracerebroventricular injection on hippocampal neurogenesis and memory deficit. J Neurochem (2012) 0.82
Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study. Malar J (2009) 0.82
Thalidomide analogue CC1069 inhibits development of rat adjuvant arthritis. Clin Exp Immunol (1999) 0.81
Mechanisms of Drug Resistance in Relapse and Refractory Multiple Myeloma. Biomed Res Int (2015) 0.81
The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro. Clin Exp Immunol (2000) 0.81
Function of the transforming growth factor-β1/c-Jun N-terminal kinase signaling pathway in the action of thalidomide on a rat model of pulmonary fibrosis. Exp Ther Med (2013) 0.81
Efficacy and safety of thalidomide in patients with hepatocellular carcinoma. World J Gastroenterol (2006) 0.81
An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma. Br J Cancer (2004) 0.81
Anti-inflammatory thalidomide improves islet grafts survival and functions in a xenogenic environment. PLoS One (2009) 0.80
Effect of thalidomide on nitric oxide production in lipopolysaccharide-activated RAW 264.7 cells. J Drugs Dermatol (2010) 0.80
Immunomodulating properties of the antibiotic novobiocin in human monocytes. Antimicrob Agents Chemother (1998) 0.80
Thalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of Inflammation. Open Biochem J (2011) 0.80
Production of transforming growth factor-beta 1 (TGF-beta1) by blood monocytes from patients with different clinical forms of leprosy. Clin Exp Immunol (2000) 0.80
Intestinal secretory factor released by macrophages stimulated with Clostridium difficile toxin A: role of interleukin 1beta. Infect Immun (1998) 0.80
IgG1 antimycobacterial antibodies can reverse the inhibitory effect of pentoxifylline on tumour necrosis factor alpha (TNF-alpha) secreted by mycobacterial antigen-stimulated adherent cells. Clin Exp Immunol (2004) 0.80
The role of anti-cytokine therapy in the failing heart. Heart Fail Rev (2001) 0.80
Immunomodulatory intervention in sepsis by multidrug-resistant Pseudomonas aeruginosa with thalidomide: an experimental study. BMC Infect Dis (2005) 0.80
Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease. Clin Rheumatol (2007) 0.79
Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic). Ther Adv Hematol (2016) 0.79
The pharmacological profile of ovalbumin-induced paw oedema in rats. Mediators Inflamm (2002) 0.78
A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response. Ecancermedicalscience (2008) 0.78
Inhibition of tumor necrosis factor alpha alters resistance to Mycobacterium avium complex infection in mice. Antimicrob Agents Chemother (1998) 0.78
A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell (1986) 36.96
Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell (1986) 15.30
Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol Cell Biol (1983) 11.06
Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science (1986) 9.19
Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science (1989) 7.78
Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J Exp Med (1989) 4.66
Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med (1991) 4.43
Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med (1990) 4.21
Phagocytosis and inflammatory stimuli induce GM-CSF mRNA in macrophages through posttranscriptional regulation. Cell (1987) 3.46
Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med (1990) 2.79
Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. J Clin Invest (1988) 2.29
Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states. Clin Exp Immunol (1991) 1.94
Interactive effects of the tumor necrosis factor promoter and 3'-untranslated regions. J Immunol (1991) 1.89
The common mediator of shock, cachexia, and tumor necrosis. Adv Immunol (1988) 1.80
Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients. J Exp Med (1992) 1.63
Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery (1991) 1.62
Transcriptional and post-transcriptional mechanisms involved in the differential expression of LPS-induced IL-1 and TNF mRNA. Immunology (1991) 1.17
Increased cyclic AMP levels enhance IL-1 alpha and IL-1 beta mRNA expression and protein production in human myelomonocytic cell lines and monocytes. J Clin Invest (1991) 1.14
T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol (1978) 28.92
Long term culture of tumour-specific cytotoxic T cells. Nature (1977) 14.15
T cell growth factor receptors. Quantitation, specificity, and biological relevance. J Exp Med (1981) 10.66
A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature (1982) 9.42
Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro. J Exp Med (1979) 8.32
T-cell growth factor. Immunol Rev (1980) 8.11
Transient expression of interleukin 2 receptors. Consequences for T cell growth. J Exp Med (1983) 5.82
The interleukin-2 T-cell system: a new cell growth model. Science (1984) 5.81
The functional relationship of the interleukins. J Exp Med (1980) 5.62
Monoclonal cytolytic T-cell lines. J Exp Med (1979) 5.28
Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines. J Exp Med (1979) 5.22
Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Proc Natl Acad Sci U S A (2001) 5.21
Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5' noncoding region. Mol Cell Biol (1988) 4.97
Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway. Proc Natl Acad Sci U S A (1984) 4.78
Interleukin 2 high-affinity receptor expression requires two distinct binding proteins. J Exp Med (1987) 4.53
Human dendritic cells. Enrichment and characterization from peripheral blood. J Exp Med (1982) 4.49
Income inequality, the psychosocial environment, and health: comparisons of wealthy nations. Lancet (2001) 4.48
Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med (1991) 4.43
Interleukin 2. Annu Rev Immunol (1984) 4.37
Interleukin 2 regulates its own receptors. Proc Natl Acad Sci U S A (1985) 4.19
Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol (1999) 4.15
Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy. N Engl J Med (1986) 4.05
Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. J Immunol (1999) 3.99
Relation between income inequality and mortality: empirical demonstration. BMJ (1999) 3.98
Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin. J Exp Med (1994) 3.94
Long-term culture of human antigen-specific cytotoxic T-cell lines. J Exp Med (1978) 3.80
Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver--conditioned medium. Cell (1990) 3.66
The interleukin 2 receptor. Functional consequences of its bimolecular structure. J Exp Med (1987) 3.66
The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes. N Engl J Med (1982) 3.52
[Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases]. Rev Rhum Mal Osteoartic (1987) 3.40
Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J Immunol (1979) 3.32
Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines. J Immunol (1980) 3.28
T-cell growth factor-mediated T-cell proliferation. Ann N Y Acad Sci (1979) 3.16
The in vitro generation and sustained culture of nude mouse cytolytic T-lymphocytes. J Exp Med (1979) 3.15
The born-again spleen. Return of splenic function after splenectomy for trauma. N Engl J Med (1978) 3.13
In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells. J Exp Med (1977) 3.11
Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science (1999) 3.10
Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics. J Immunol (1983) 3.10
Phorbol esters, phospholipase C, and growth factors rapidly stimulate the phosphorylation of a Mr 80,000 protein in intact quiescent 3T3 cells. Proc Natl Acad Sci U S A (1983) 2.84
Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J Exp Med (1990) 2.79
Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory. J Exp Med (1991) 2.78
Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2. J Exp Med (1983) 2.61
Mutational analysis of upstream AUG codons of poliovirus RNA. J Virol (1988) 2.55
Staphylococcus aureus RN6390 replicates and induces apoptosis in a pulmonary epithelial cell line. Infect Immun (2000) 2.54
Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset. J Exp Med (1998) 2.39
Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements. AJNR Am J Neuroradiol (2008) 2.34
Heterogeneity of human T-cell growth factor(s) due to variable glycosylation. Mol Immunol (1981) 2.34
Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. J Immunol (1987) 2.27
Interleukin-2 induction of T-cell G1 progression and c-myb expression. Science (1986) 2.26
Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures. J Exp Med (1983) 2.24
Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect Immun (1997) 2.19
Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients. Am J Pathol (1987) 2.18
Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function. J Exp Med (1985) 2.14
PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood (2000) 2.12
Influence of delayed immune reactions on human epidermal keratinocytes. Proc Natl Acad Sci U S A (1986) 2.11
T-cell growth factor and the culture of cloned functional T cells. Adv Immunol (1981) 2.09
Antigen-specific T lymphocytes efficiently cluster with dendritic cells in the human primary mixed-leukocyte reaction. Cell Immunol (1988) 2.08
In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen. J Exp Med (1982) 2.02
Lymphocyte activating factor promotes T-cell growth factor production by cloned murine lymphoma cells. Nature (1980) 1.99
Characterization of poliovirus conformational alteration mediated by soluble cell receptors. Virology (1993) 1.97
The effect of T cell growth factor on the generation of cytolytic T cells. J Immunol (1978) 1.92
Acupuncture for osteoarthritis of the knee: a systematic review. Arthritis Rheum (2001) 1.91
Relationship between premature mortality and socioeconomic factors in black and white populations of US metropolitan areas. Public Health Rep (2002) 1.91
Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent. Infect Immun (2000) 1.91
Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infect Immun (1999) 1.90
Translational efficiency of poliovirus mRNA: mapping inhibitory cis-acting elements within the 5' noncoding region. J Virol (1988) 1.85
Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization. J Exp Med (1989) 1.82
Fc-receptor variants of a mouse macrophage cell line. Proc Natl Acad Sci U S A (1979) 1.80
TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways. J Immunol (2001) 1.79
In vitro synthesis of infectious poliovirus RNA. Proc Natl Acad Sci U S A (1985) 1.78
Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am J Respir Cell Mol Biol (1999) 1.77
T-cell growth factor: complete nucleotide sequence and organization of the gene in normal and malignant cells. Proc Natl Acad Sci U S A (1984) 1.77
Distribution and turnover of Langerhans cells during delayed immune responses in human skin. J Exp Med (1987) 1.74
Differences in the mode of phagocytosis with Fc and C3 receptors in macrophages. Scand J Immunol (1977) 1.71
The distinctive features of influenza virus infection of dendritic cells. Immunobiology (1998) 1.70
Functional and molecular characteristics of T-cell growth factor. Mol Immunol (1980) 1.66
Covariation of activity in habenula and dorsal raphé nuclei following tryptophan depletion. Neuroimage (1999) 1.65
Glucocorticoids and immune responses. Arthritis Rheum (1979) 1.65
Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients. J Exp Med (1992) 1.63
Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production. Bioorg Med Chem Lett (1999) 1.62
Juvenile chronic arthritis: diagnosis and management of tibio-talar and sub-talar disease. Br J Rheumatol (1997) 1.62
Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis. J Infect Dis (1998) 1.62
Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1993) 1.61
Insertion and turnover of macrophage plasma membrane proteins. Proc Natl Acad Sci U S A (1979) 1.60
Ultrafast computed tomography-detected coronary calcium reflects the angiographic extent of coronary arterial atherosclerosis. Am J Cardiol (1994) 1.59
Role of activated macrophages in antibody-dependent lysis of tumor cells. J Exp Med (1980) 1.58
Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance. Immunol Rev (1995) 1.58
The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology (Berl) (2002) 1.56
Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro. J Infect Dis (1996) 1.55
The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum. J Infect Dis (1993) 1.55
The development of sequence-tagged sites for human chromosome 4. Hum Mol Genet (1993) 1.55
Induction of antigen-specific parasiticidal cytotoxic T cell splenocytes by a major membrane protein (P30) of Toxoplasma gondii. J Immunol (1988) 1.54
Glucocorticoid-induced inhibition of T cell growth factor production. II. The effect on the in vitro generation of cytolytic T cells. J Immunol (1979) 1.53
An analysis of in vitro T cell responsiveness in lepromatous leprosy. J Exp Med (1985) 1.52
Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proc Natl Acad Sci U S A (1992) 1.52
The cutaneous infiltrates of leprosy. A transmission electron microscopy study. J Exp Med (1983) 1.51
Both interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factors in IgM synthesis. J Exp Med (1984) 1.51
c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function. Int Immunol (1999) 1.48
Use of acupuncture by American physicians. J Altern Complement Med (1997) 1.47